Nicholas Investment Partners, LP Deciphera Pharmaceuticals, Inc. Transaction History

Nicholas Investment Partners, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 10, 2021	SELL	$32.73 - $47.95 $14.6 Million - $21.4 Million	-446,674 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$40.39 - $56.73 $7.51 Million - $10.5 Million	185,876 Added 71.27%	446,674 $20 Million
Q4 2020 Feb 11, 2021	BUY	$51.77 - $66.18 $2.27 Million - $2.9 Million	43,815 Added 20.19%	260,798 $14.9 Million
Q3 2020 Nov 13, 2020	BUY	$43.8 - $58.16 $7.44 Million - $9.88 Million	169,872 Added 360.58%	216,983 $11.1 Million
Q2 2020 Aug 12, 2020	SELL	$37.05 - $65.03 $1.9 Million - $3.33 Million	-51,188 Reduced 52.07%	47,111 $2.81 Million
Q1 2020 May 13, 2020	BUY	$33.63 - $69.4 $3.31 Million - $6.82 Million	98,299 New	98,299 $4.05 Million

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Nicholas Investment Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Nicholas Investment Partners, LP with notifications on news.